Who we are

The Muscular Dystrophy Campaign is the leading UK charity focusing on muscular dystrophy and other related conditions. We are dedicated to beating muscular dystrophy and other related conditions by finding treatments and cures and to improving the lives of everyone affected by them.

Our history

The Muscular Dystrophy Campaign has a very proud history. We were set up in 1959 to help families and children living with muscular dystrophy.

Our main aim was to raise money to fund research to find the causes of and cures for muscular dystrophy. Since then diagnosis of the different forms of muscular dystrophy and related muscle diseases has improved hugely and we now provide support for more than 60 different muscle-wasting conditions. We have funded many key research developments during the years, including vital pre-clinical research for the exon skipping trial that is testing an exciting new technology to treat Duchenne muscular dystrophy.

Today we play an active role in nationwide lobbying and  campaigning for changes to improve the support given to patients and to raise awareness of muscular dystrophy and related conditions. We have also made vital contributions to improvements in people's quality of life through emotional and practical support and grants towards the cost of specialist equipment, and we provide specialist education and development for health professionals.  

Our Vision

We aim to find treatments and ultimately cures for muscular dystrophy and related conditions and improve the lives of all those people affected by them in the UK. We act to make a real difference for people affected by muscular dystrophy and related conditions.

• We are committed to leading the research for effective prevention, treatments and cure
• We are dedicated to improving the lives of everyone affected by muscular dystrophy and related conditions
• We are leading the fight against muscular dystrophy and related neuromuscular conditions
• We believe specialist services should be available locally for everyone affected by muscular dystrophy and related neuromuscular conditions
• We are committed to providing up to date communications on research to patients, families and the science and medical communities.